Cargando…

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib

The aim of this study was to determine whether skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma (HCC) that is being treated with sorafenib. We evaluated 40 consecutive HCC patients who received sorafenib treatment. The skeletal muscle cross-sectional area wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imai, Kenji, Takai, Koji, Hanai, Tatsunori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Suetsugu, Atsushi, Shiraki, Makoto, Shimizu, Masahito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463608/ https://www.ncbi.nlm.nih.gov/pubmed/25927582 http://dx.doi.org/10.3390/ijms16059612

Ejemplares similares

Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Imai, Kenji, et al.
Publicado: (2019)

Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma
por: Imai, Kenji, et al.
Publicado: (2020)

Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume
por: Imai, Kenji, et al.
Publicado: (2017)

Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment
por: Imai, Kenji, et al.
Publicado: (2019)

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2020)

Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates
por: Imai, Kenji, et al.
Publicado: (2023)

Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report
por: Miwa, Takao, et al.
Publicado: (2021)

Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2020)

Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2018)

Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment
por: Imai, Kenji, et al.
Publicado: (2021)

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2020)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
por: Hanai, Tatsunori, et al.
Publicado: (2021)

FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma
por: Imai, Kenji, et al.
Publicado: (2023)

Changes in ALBI Score and PIVKA-II within Three Months after Commencing Atezolizumab Plus Bevacizumab Treatment Affect Overall Survival in Patients with Unresectable Hepatocellular Carcinoma
por: Unome, Shinji, et al.
Publicado: (2022)

Chemopreventive Potential of Green Tea Catechins in Hepatocellular Carcinoma
por: Shimizu, Masahito, et al.
Publicado: (2015)

Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers
por: Imai, Kenji, et al.
Publicado: (2021)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
por: Ideta, Takayasu, et al.
Publicado: (2015)

Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease
por: Nakahata, Yuki, et al.
Publicado: (2023)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2023)

Development of diffuse large B-cell lymphoma after sofosbuvir-ledipasvir treatment for chronic hepatitis C: A case report and literature review
por: Sakai, Hiroyasu, et al.
Publicado: (2020)

Usefulness of the Trabecular Bone Score in Assessing the Risk of Vertebral Fractures in Patients with Cirrhosis
por: Ogiso, Yui, et al.
Publicado: (2022)

Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice
por: Miyazaki, Tsuneyuki, et al.
Publicado: (2016)

Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study
por: Miwa, Takao, et al.
Publicado: (2022)

Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma
por: Imai, Kenji, et al.
Publicado: (2014)

A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis
por: Miwa, Takao, et al.
Publicado: (2022)

Association between Body Composition and the Risk of Portopulmonary Hypertension Assessed by Computed Tomography in Patients with Liver Cirrhosis
por: Miwa, Takao, et al.
Publicado: (2023)

Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice
por: Obara, Koki, et al.
Publicado: (2017)

Non-alcoholic steatohepatitis-related liver tumorigenesis is suppressed in mice lacking hepatic retinoid storage
por: Ideta, Takayasu, et al.
Publicado: (2017)

Mac-2-binding protein glycosylation isomer is useful to predict muscle cramps in patients with chronic liver disease
por: Miwa, Takao, et al.
Publicado: (2022)

Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats
por: Shirakami, Yohei, et al.
Publicado: (2021)

Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012)

Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment
por: Watanabe, Naoki, et al.
Publicado: (2011)

Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
por: Miyazaki, Tsuneyuki, et al.
Publicado: (2021)

(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis
por: Sumi, Takafumi, et al.
Publicado: (2013)

Systemic and topical administration of spermidine accelerates skin wound healing
por: Ito, Daisuke, et al.
Publicado: (2021)

Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
por: Ikeda, Atsuyuki, et al.
Publicado: (2021)

Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review
por: Miwa, Takao, et al.
Publicado: (2020)

Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
por: Ito, Daisuke, et al.
Publicado: (2023)

Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy
por: Ninomiya, Soranobu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_joggl712vc1l7v2maebpc7r4v3